Abingdon Health (LON:ABDX) Announces Quarterly Earnings Results

Abingdon Health (LON:ABDX – Get Free Report) released its earnings results on Tuesday. The company reported GBX (0.51) EPS for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

Abingdon Health Stock Performance

Shares of ABDX traded up GBX 0.50 on Thursday, reaching GBX 9.50. 43,498 shares of the stock traded hands, compared to its average volume of 234,760. The stock’s 50-day moving average price is GBX 10.70 and its 200-day moving average price is GBX 10.53. The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. The firm has a market cap of £24.01 million, a price-to-earnings ratio of -11.73 and a beta of 0.13. Abingdon Health has a 12 month low of GBX 5.50 and a 12 month high of GBX 13.

Abingdon Health Company Profile

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.

Further Reading

Earnings History for Abingdon Health (LON:ABDX)

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.